Cargando…
Favipiravir and the Need for Early Ambulatory Treatment of COVID-19
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Microbiology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092553/ https://www.ncbi.nlm.nih.gov/pubmed/33288636 http://dx.doi.org/10.1128/AAC.02489-20 |
| _version_ | 1783687663157510144 |
|---|---|
| author | Korman, Tony M. |
| author_facet | Korman, Tony M. |
| author_sort | Korman, Tony M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8092553 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American Society for Microbiology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80925532021-05-05 Favipiravir and the Need for Early Ambulatory Treatment of COVID-19 Korman, Tony M. Antimicrob Agents Chemother Letter to the Editor American Society for Microbiology 2021-02-17 /pmc/articles/PMC8092553/ /pubmed/33288636 http://dx.doi.org/10.1128/AAC.02489-20 Text en Copyright © 2021 American Society for Microbiology. https://doi.org/10.1128/ASMCopyrightv2All Rights Reserved (https://doi.org/10.1128/ASMCopyrightv2) . https://doi.org/10.1128/ASMCopyrightv2This article is made available via the PMC Open Access Subset for unrestricted noncommercial re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Korman, Tony M. Favipiravir and the Need for Early Ambulatory Treatment of COVID-19 |
| title | Favipiravir and the Need for Early Ambulatory Treatment of COVID-19 |
| title_full | Favipiravir and the Need for Early Ambulatory Treatment of COVID-19 |
| title_fullStr | Favipiravir and the Need for Early Ambulatory Treatment of COVID-19 |
| title_full_unstemmed | Favipiravir and the Need for Early Ambulatory Treatment of COVID-19 |
| title_short | Favipiravir and the Need for Early Ambulatory Treatment of COVID-19 |
| title_sort | favipiravir and the need for early ambulatory treatment of covid-19 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092553/ https://www.ncbi.nlm.nih.gov/pubmed/33288636 http://dx.doi.org/10.1128/AAC.02489-20 |
| work_keys_str_mv | AT kormantonym favipiravirandtheneedforearlyambulatorytreatmentofcovid19 |